TXG

10x Genomics (TXG) Investor Questions

10x Genomics (TXG) investor questions: stock forecasts, price data, dividends, earnings dates, valuation and risk, with missing data clearly identified.

Research record updated: . Individual measures may refer to different reporting periods.

Company
10x Genomics
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
56
Annual revenue
$642.82M
Annual net income
$-43.54M
Annual free cash flow
$130.12M

10x Genomics (TXG) Investor Questions research

10x Genomics trades under the ticker TXG. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review TXG through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.

What is 10x Genomics (TXG) stock?

10x Genomics trades under ticker TXG. Its recorded sector is Healthcare. Its industry is Biotechnology.

What does the TXG stock forecast mean?

BTI's forecast summarizes available short-term and long-term research scores for TXG. These scores are not price targets, analyst consensus or probabilities of a positive return. Compare the Forecast, Earnings and Valuation pages before interpreting the outlook.

Where can I find the TXG stock price today?

Check the TXG quote and chart in the research workspace, including currency, trading session and quote timestamp. The research-record update time on this page is not a live quote timestamp.

Does TXG pay dividends?

Dividend yield is not supplied in this TXG research record. Missing data does not establish that 10x Genomics does not pay dividends. Check the company's dividend announcements for declared amounts and dates.

When does TXG report earnings?

The available earnings record lists 2026-08-06 for TXG. This stored date may be historical; it is not confirmation of the next announcement. Check 10x Genomics's investor-relations calendar for the current schedule; estimated dates can change.

How can I assess TXG's valuation and risk?

Compare 10x Genomics's financial results, cash flow, debt and valuation assumptions with its operating risks and competitors. The Financials, Valuation and Statistics pages provide the available figures. A BTI score is a research input, not a personalized recommendation.